Related Experiment Video
Updated: Jun 4, 2026
13:27
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
Therapy in pneumonia: what is beyond antibiotics?
S C A Meijvis1, J C Grutters, S F Thijsen
1Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, the Netherlands.
The Netherlands Journal of Medicine
|February 18, 2011
Summary
Community-acquired pneumonia (CAP) treatment faces challenges from increasing antibiotic resistance and severe inflammation. This review explores promising non-antibiotic therapies to manage inflammation and combat resistant bacteria in CAP patients.
Area of Science:
- Infectious Diseases
- Pulmonology
- Pharmacology
Background:
- Community-acquired pneumonia (CAP) is a significant cause of mortality, morbidity, and healthcare expenditure.
- Pneumonia severity correlates with the intensity of the inflammatory response.
- Rising antimicrobial resistance complicates effective CAP treatment.
Purpose of the Study:
- To review current knowledge on adjunctive non-antibiotic therapies for CAP.
- To explore strategies that modulate the inflammatory response in pneumonia.
- To investigate novel approaches targeting the causative microorganisms of CAP.
Main Methods:
- Literature review of existing studies on non-antibiotic treatments for CAP.
- Analysis of therapeutic strategies focusing on inflammation modulation.
- Evaluation of therapies targeting microbial factors in pneumonia.
Main Results:
- Discussion of various non-antibiotic agents and their mechanisms of action.
- Assessment of the potential impact of these therapies on reducing inflammation.
- Exploration of how these agents may overcome antimicrobial resistance.
Conclusions:
- Adjunctive non-antibiotic therapies show potential in managing CAP.
- Modulating the inflammatory response is a key target for novel CAP treatments.
- Future research should focus on integrating these strategies to improve CAP outcomes.
Related Concept Videos
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...